All Curated Mutation Sites in HBV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
S
  
BCP
  
X
  
C
  
Core Promoter
  
Core Upstream Regulatory Sequence
  
DR1
  
EnhI
  
EnhII
  
PreC
  
P
  
PreC Promoter
  
PreS
  
PreS1
  
PreS1 Promoter
  
PreS2
  
RT
  
S Promoter
  
S1 Promoter
  
S2 Promoter
  
X Promoter
  

Keyword: Liver Diseases-25658544
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 25658544 A2525T
P
P
Liver Diseases
L
View
2 25658544 C2288A
C
C
Liver Diseases
L
View
3 25658544 C2288T
C
C
Liver Diseases
L
View
4 25658544 C2304A
C
C
Liver Diseases
L
View
5 25658544 G2525C
P
P
Liver Diseases
L
View
6 25658544 G2525T
P
P
Liver Diseases
L
View
7 25658544 A2525C
P
P
Liver Diseases
L
View
8 25658544 E73D
P
P
Liver Diseases
L
View
9 25658544 K73N
P
P
Liver Diseases
L
View
10 25658544 P130S
C
C
Liver Diseases
L
View
11 25658544 P130T
C
C
Liver Diseases
L
View
12 25658544 P135Q
C
C
Liver Diseases
L
View
13 25658544 A1329C Liver Diseases
L
View
14 25658544 A1329T Liver Diseases
L
View
15 25658544 A1703G Liver Diseases
L
View
16 25658544 A1727G Liver Diseases
L
View
17 25658544 A1752G Liver Diseases
L
View
18 25658544 A2221C Liver Diseases
L
View
19 25658544 A2221T Liver Diseases
L
View
20 25658544 A2739C Liver Diseases
L
View
21 25658544 A930C Liver Diseases
L
View
22 25658544 A930G Liver Diseases
L
View
23 25658544 A930T Liver Diseases
L
View
24 25658544 A993G Liver Diseases
L
View
25 25658544 C1218A Liver Diseases
L
View
26 25658544 C1218T Liver Diseases
L
View
27 25658544 C1479A Liver Diseases
L
View
28 25658544 C1479T Liver Diseases
L
View
29 25658544 C3000T Liver Diseases
L
View
30 25658544 C3116T Liver Diseases
L
View
31 25658544 G1230C Liver Diseases
L
View
32 25658544 G2095A Liver Diseases
L
View
33 25658544 G2699A Liver Diseases
L
View
34 25658544 G2699C Liver Diseases
L
View
35 25658544 G2699T Liver Diseases
L
View
36 25658544 G915A Liver Diseases
L
View
37 25658544 T2005A Liver Diseases
L
View
38 25658544 T2201C Liver Diseases
L
View
39 25658544 T31C Liver Diseases
L
View
40 25658544 A1762T
X
X
Liver Diseases
L
View
41 25658544 A1846T
Core Promoter
Liver Diseases
L
View
42 25658544 A2189C
C
C
Liver Diseases
L
View
43 25658544 A2189T
C
C
Liver Diseases
L
View
44 25658544 C1653T
X
X
Liver Diseases
L
View
45 25658544 G1613A
X
X
Liver Diseases
L
View
46 25658544 G1764A
X
X
Liver Diseases
L
View
47 25658544 G1896A
C
C
Liver Diseases
L
View
Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.